SmartRent, Inc. (SMRT): Nasdaq/NYSE listing notice — SmartRent gets NYSE delisting notice for sub-$1.00 stock price; has 6 months to cure

SmartRent, Inc.

Received NYSE notice on May 2, 2025 for non-compliance with minimum $1.00 average closing price over 30 trading days.
Has six-month cure period to regain compliance by achieving closing price ≥$1.00 and 30-day average ≥$1.00.
Intends to notify NYSE of cure plan; may pursue reverse stock split if needed, subject to board and shareholder approval.
Stock continues trading on NYSE during cure period; failure to cure could lead to suspension and delisting.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

SmartRent, Inc. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

Exchange: nyse
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 802.01C

Exact text from the filing

May 2, 2025, SmartRent, Inc. (the “Company”) received notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing share price of the Company’s Class A common stock as of May 2, 2025 was less than $1.00 over a consecutive 30 trading-day period. As required by the NYSE, the Company intends to provide timely notice to the NYSE of its intent to regain compliance with the NYSE minimum share price requirement, which may include, if necessary, effecting a reverse stock split, subjec

View on SEC.gov

93 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

SmartRent, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-25-063018

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.